Market Research Logo

Proteon Therapeutics Inc (PRTO) - Financial and Strategic SWOT Analysis Review

Proteon Therapeutics Inc (PRTO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its product candidate includes vonapanitase, an investigational drug intended to treat vessel injury that leads to blood vessel blockage and reduced blood flow. Proteon Therapeutics’ vonapanitase is under Phase 3 clinical study in hemodialysis vascular access. The company’s product is also studied in patients with peripheral arterial disease. It owns and operates research facilities in Kansas City, Missouri. Proteon Therapeutics is headquartered in Waltham, Massachusetts, the US.

Proteon Therapeutics Inc Key Recent Developments

Nov 07,2017: Proteon Therapeutics Announces Third Quarter 2017 Financial Results
Aug 07,2017: Proteon Therapeutics Announces Second Quarter 2017 Financial Results
May 10,2017: Proteon Therapeutics Announces First Quarter 2017 Financial Results
May 10,2017: Proteon Therapeutics Q1 net loss decreases
Mar 16,2017: Proteon Therapeutics annual net loss increases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Proteon Therapeutics Inc - Key Facts 5
Proteon Therapeutics Inc - Key Employees 6
Proteon Therapeutics Inc - Key Employee Biographies 7
Proteon Therapeutics Inc - Major Products and Services 8
Proteon Therapeutics Inc - History 9
Proteon Therapeutics Inc - Company Statement 10
Proteon Therapeutics Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Proteon Therapeutics Inc - Business Description 14
Proteon Therapeutics Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Proteon Therapeutics Inc - Strengths 15
Proteon Therapeutics Inc - Weaknesses 16
Proteon Therapeutics Inc - Opportunities 17
Proteon Therapeutics Inc - Threats 18
Proteon Therapeutics Inc - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Proteon Therapeutics Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Nov 07, 2017: Proteon Therapeutics Announces Third Quarter 2017 Financial Results 29
Aug 07, 2017: Proteon Therapeutics Announces Second Quarter 2017 Financial Results 31
May 10, 2017: Proteon Therapeutics Announces First Quarter 2017 Financial Results 33
May 10, 2017: Proteon Therapeutics Q1 net loss decreases 35
Mar 16, 2017: Proteon Therapeutics annual net loss increases 36
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Proteon Therapeutics Inc, Key Facts 5
Proteon Therapeutics Inc, Key Employees 6
Proteon Therapeutics Inc, Key Employee Biographies 7
Proteon Therapeutics Inc, Major Products and Services 8
Proteon Therapeutics Inc, History 9
Proteon Therapeutics Inc, Subsidiaries 13
Proteon Therapeutics Inc, Key Competitors 19
Proteon Therapeutics Inc, Ratios based on current share price 20
Proteon Therapeutics Inc, Annual Ratios 21
Proteon Therapeutics Inc, Annual Ratios (Cont...1) 22
Proteon Therapeutics Inc, Interim Ratios 24
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Proteon Therapeutics Inc, Recent Deals Summary 28
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40
List of Figures
Proteon Therapeutics Inc, Performance Chart (2012 - 2016) 23
Proteon Therapeutics Inc, Ratio Charts 25
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report